Dr. Christian Flynn, MBChB, BSc (Hons), MSc (Dist), NIHR Academic Clinical Fellow at Leeds Teaching Hospitals NHS Trust, is a clinician driving innovation in various specialities. In clinical development at XYRA, he is involved with the Phase 3 development of budiodarone, a novel antiarrhythmic for non-permanent atrial fibrillation, integrating wearable technology with an aim to deliver enhanced patient monitoring, personalised dose titration and improved outcomes. With a background in clinical trials, regulatory strategy, and digital health innovation, Dr. Flynn has been involved with mid-late stage trial planning, securing FDA alignments and strategic partnerships. His work bridges academic research and clinical practice, with roles Renexxion and Alder Hey Innovation. Dr. Flynn holds an MSc in Global Healthcare Leadership and certifications in artificial intelligence, reflecting his commitment to advancing global patient care through cutting-edge research and technology.